Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 26 | 2023 | 2063 | 2.120 |
Why?
|
| Brain | 24 | 2023 | 1642 | 1.960 |
Why?
|
| Transcriptome | 9 | 2023 | 80 | 1.760 |
Why?
|
| Proteomics | 6 | 2022 | 90 | 1.170 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 125 | 1.130 |
Why?
|
| Algorithms | 4 | 2023 | 358 | 1.100 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 1020 | 1.040 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 30 | 0.980 |
Why?
|
| Proteome | 3 | 2022 | 41 | 0.970 |
Why?
|
| RNA, Messenger | 3 | 2022 | 264 | 0.950 |
Why?
|
| Cluster Analysis | 2 | 2023 | 38 | 0.730 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 236 | 0.700 |
Why?
|
| Nerve Net | 2 | 2019 | 46 | 0.680 |
Why?
|
| Dementia | 2 | 2022 | 527 | 0.650 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2023 | 373 | 0.570 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 282 | 0.530 |
Why?
|
| Models, Neurological | 1 | 2016 | 24 | 0.530 |
Why?
|
| Humans | 41 | 2023 | 26028 | 0.500 |
Why?
|
| Models, Theoretical | 1 | 2015 | 77 | 0.490 |
Why?
|
| DNA Methylation | 5 | 2022 | 119 | 0.490 |
Why?
|
| Aged, 80 and over | 17 | 2022 | 4660 | 0.490 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.480 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.480 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.480 |
Why?
|
| Aging | 8 | 2023 | 1535 | 0.480 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 43 | 0.470 |
Why?
|
| Gene Expression | 5 | 2023 | 179 | 0.460 |
Why?
|
| Microglia | 5 | 2023 | 135 | 0.420 |
Why?
|
| Genome, Human | 3 | 2018 | 41 | 0.420 |
Why?
|
| Cognition | 6 | 2021 | 1290 | 0.410 |
Why?
|
| Aged | 19 | 2023 | 8705 | 0.410 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 159 | 0.380 |
Why?
|
| Genotype | 4 | 2019 | 335 | 0.370 |
Why?
|
| Male | 22 | 2022 | 14011 | 0.360 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 26 | 0.360 |
Why?
|
| Female | 21 | 2022 | 14399 | 0.350 |
Why?
|
| Hormones | 1 | 2010 | 8 | 0.350 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 98 | 0.350 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 318 | 0.330 |
Why?
|
| Autopsy | 6 | 2019 | 338 | 0.320 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 68 | 0.310 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 244 | 0.300 |
Why?
|
| Cohort Studies | 8 | 2020 | 1823 | 0.290 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 53 | 0.270 |
Why?
|
| Motor Activity | 2 | 2019 | 318 | 0.260 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 43 | 0.250 |
Why?
|
| Phenotype | 4 | 2023 | 290 | 0.250 |
Why?
|
| Benchmarking | 1 | 2023 | 35 | 0.220 |
Why?
|
| Apolipoproteins E | 3 | 2020 | 250 | 0.210 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 24 | 0.210 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 143 | 0.200 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 18 | 0.200 |
Why?
|
| Mutation | 2 | 2014 | 311 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 149 | 0.200 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 83 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 18 | 0.200 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 37 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 4 | 0.200 |
Why?
|
| Astrocytes | 2 | 2020 | 131 | 0.190 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 109 | 0.190 |
Why?
|
| Neurons | 4 | 2021 | 309 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 19 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2020 | 151 | 0.190 |
Why?
|
| Models, Genetic | 3 | 2020 | 26 | 0.190 |
Why?
|
| Haplotypes | 2 | 2020 | 54 | 0.190 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 191 | 0.180 |
Why?
|
| Peptides | 1 | 2021 | 97 | 0.180 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 5 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2021 | 89 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 96 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 39 | 0.170 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 7 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2019 | 13 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 202 | 0.170 |
Why?
|
| Histones | 1 | 2019 | 24 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 16 | 0.170 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.170 |
Why?
|
| Seasons | 1 | 2018 | 21 | 0.160 |
Why?
|
| Independent Living | 2 | 2019 | 307 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2019 | 133 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 11 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 2018 | 82 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 114 | 0.150 |
Why?
|
| Risk Factors | 6 | 2019 | 2244 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 74 | 0.140 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 254 | 0.140 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1140 | 0.140 |
Why?
|
| Homozygote | 1 | 2017 | 18 | 0.140 |
Why?
|
| Postural Balance | 1 | 2018 | 117 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 132 | 0.140 |
Why?
|
| Inflammation | 1 | 2018 | 264 | 0.130 |
Why?
|
| Lewy Bodies | 4 | 2019 | 193 | 0.130 |
Why?
|
| tau Proteins | 3 | 2021 | 225 | 0.120 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 8 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 16 | 0.120 |
Why?
|
| Exercise | 1 | 2019 | 453 | 0.120 |
Why?
|
| Mitochondria | 1 | 2014 | 57 | 0.120 |
Why?
|
| Fibromyalgia | 1 | 2014 | 28 | 0.120 |
Why?
|
| Gait | 1 | 2018 | 408 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 1223 | 0.110 |
Why?
|
| Behavior | 1 | 2013 | 21 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 28 | 0.110 |
Why?
|
| Amygdala | 2 | 2010 | 40 | 0.110 |
Why?
|
| Animals | 5 | 2020 | 3390 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 67 | 0.100 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 29 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 1281 | 0.100 |
Why?
|
| Linear Models | 3 | 2018 | 240 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1340 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2010 | 41 | 0.090 |
Why?
|
| Homeostasis | 1 | 2010 | 50 | 0.090 |
Why?
|
| Alleles | 2 | 2021 | 201 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 335 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 272 | 0.080 |
Why?
|
| Sclerosis | 2 | 2019 | 66 | 0.080 |
Why?
|
| Schizophrenia | 2 | 2018 | 66 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 549 | 0.070 |
Why?
|
| Hippocampus | 2 | 2019 | 261 | 0.070 |
Why?
|
| Species Specificity | 2 | 2020 | 41 | 0.070 |
Why?
|
| Bayes Theorem | 2 | 2015 | 39 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 11 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 7 | 0.060 |
Why?
|
| Base Sequence | 1 | 2023 | 89 | 0.060 |
Why?
|
| DNA | 1 | 2023 | 93 | 0.060 |
Why?
|
| Organ Size | 1 | 2023 | 95 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 568 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 104 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 33 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 5 | 0.050 |
Why?
|
| Computational Biology | 1 | 2020 | 21 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 37 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 22 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 42 | 0.040 |
Why?
|
| Lysosomes | 1 | 2020 | 25 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 24 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 91 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 670 | 0.040 |
Why?
|
| Pharmacology | 1 | 2019 | 2 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 200 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 14 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 118 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 550 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 17 | 0.040 |
Why?
|
| Metabolomics | 1 | 2018 | 17 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 141 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 15 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 16 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 8509 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 11 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 37 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 79 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 115 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 92 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 113 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 43 | 0.040 |
Why?
|
| Epigenomics | 1 | 2017 | 13 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 88 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2017 | 32 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 362 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 8 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 94 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 99 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 94 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 844 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 204 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 325 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 210 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1659 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 7364 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 15 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 32 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 856 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 250 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 57 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 30 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 49 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 150 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 442 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 61 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1712 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2018 | 986 | 0.020 |
Why?
|
| United States | 1 | 2017 | 1981 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 826 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 49 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 17 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 97 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 93 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 416 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 212 | 0.020 |
Why?
|